ANTI-OBESITY MEDICATIONS, THE NEW FRONTIERS IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: EFFICACY, LIMITATIONS, AND FUTURE DIRECTIONS